Cargando…

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?

Diabetic nephropathy (DN), one of the most serious microvascular complications of diabetes mellitus (DM), may progress to end-stage renal disease (ESRD). Current biochemical biomarkers, such as urinary albumin excretion rate (UAER), have limitations for early screening and monitoring of DN. Recent s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Xiaodie, Yang, Min, Ling, Peiyao, Wu, Aihua, Zhou, Hua, Jiang, Jingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811266/ https://www.ncbi.nlm.nih.gov/pubmed/35125878 http://dx.doi.org/10.2147/DMSO.S350233

Ejemplares similares

Acylcarnitines in Ophthalmology: Promising Emerging Biomarkers
por: Theodoridis, Konstantinos, et al.
Publicado: (2022)

Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
por: Mu, Xiaodie, et al.
Publicado: (2023)

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
por: Mu, Xiaodie, et al.
Publicado: (2022)

The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus
por: Li, Xuerui, et al.
Publicado: (2023)

L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine
por: McCann, Marc R., et al.
Publicado: (2021)

Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy
por: Xia, Fang-Ying, et al.
Publicado: (2019)

Acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency in newborns
por: Tan, Yifei, et al.
Publicado: (2023)

Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
por: Lo, Chi-Jen, et al.
Publicado: (2023)

NMR Characterization of Long-Chain Fatty Acylcarnitine Binding to the Mitochondrial Carnitine/Acylcarnitine Carrier
por: Zhang, Ningning, et al.
Publicado: (2022)

Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues
por: Makrecka-Kuka, Marina, et al.
Publicado: (2017)

Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma
por: Li, Shangfu, et al.
Publicado: (2019)

The significance of acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency
por: Shi, Congcong, et al.
Publicado: (2023)

Correlation between Acylcarnitine and Peripheral Neuropathy in Type 2 Diabetes Mellitus
por: An, Zhenni, et al.
Publicado: (2022)

Tubulointerstitial Biomarkers for Diabetic Nephropathy
por: Satirapoj, Bancha
Publicado: (2018)

Enhanced Acylcarnitine Annotation in High-Resolution Mass Spectrometry Data: Fragmentation Analysis for the Classification and Annotation of Acylcarnitines
por: van der Hooft, Justin J. J., et al.
Publicado: (2015)

Postmortem Metabolomics Reveal Acylcarnitines as Potential Biomarkers for Fatal Oxycodone-Related Intoxication
por: Elmsjö, Albert, et al.
Publicado: (2022)

Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients
por: Takaya, Hiroaki, et al.
Publicado: (2019)

Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel Disease
por: Lemons, Johanna M.S., et al.
Publicado: (2023)

Acylcarnitines: Reflecting or Inflicting Insulin Resistance?
por: Schooneman, Marieke G., et al.
Publicado: (2013)

Plasma acylcarnitines are associated with pulmonary hypertension
por: Luo, Nancy, et al.
Publicado: (2017)

Relationship Between Acylcarnitine and the Risk of Retinopathy in Type 2 Diabetes Mellitus
por: Wang, Wan-Ying, et al.
Publicado: (2022)

Plasma acylcarnitine and diabetic retinopathy: A study from Eastern China
por: Jin, Dongzhen, et al.
Publicado: (2022)

Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy
por: Lv, Jiarong, et al.
Publicado: (2020)

Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity
por: Shi, Congcong, et al.
Publicado: (2023)

Proteomic and bioinformatic discovery of biomarkers for diabetic nephropathy
por: Thippakorn, Chadinee, et al.
Publicado: (2018)

Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy
por: Gluhovschi, Cristina, et al.
Publicado: (2016)

Serum Levels of Acylcarnitines Are Altered in Prediabetic Conditions
por: Mai, Manuel, et al.
Publicado: (2013)

Sexual dimorphism in myocardial acylcarnitine and triglyceride metabolism
por: Devanathan, Sriram, et al.
Publicado: (2016)

The brain acylcarnitine profile depends on nutritional state
por: Svalbe, Baiba, et al.
Publicado: (2015)

Acylcarnitine profiling by low-resolution LC-MS
por: Meierhofer, David
Publicado: (2019)

Plasma acylcarnitine levels increase with healthy aging
por: Jarrell, Zachery R., et al.
Publicado: (2020)

High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal fluid: identification of PCNSL biomarkers and potential metabolic messengers
por: Ma, Jingjing, et al.
Publicado: (2023)

Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients
por: Fiseha, Temesgen
Publicado: (2015)

Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?
por: Aziz, Sohail, et al.
Publicado: (2021)

Diagnosis of atypical myopathy based on organic acid and acylcarnitine profiles and evolution of biomarkers in surviving horses
por: Mathis, Déborah, et al.
Publicado: (2021)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
por: Jia, Zhanjun, et al.
Publicado: (2014)

Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China
por: Zhou, Duo, et al.
Publicado: (2022)

The role of novel biomarkers in predicting diabetic nephropathy: a review
por: Uwaezuoke, Samuel N
Publicado: (2017)

Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
por: Hu, Qichao, et al.
Publicado: (2021)

Biomarkers of progression in diabetic nephropathy: The past, present and future
por: Lee, Chi-Ho, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_90queiavebcqm0e98l4go6f0q8